Hims compounded semaglutide is a subscription-based telehealth program offered by Hims and Hers Health that connects adults with prescribing clinicians and 503A compounding pharmacies for GLP-1 weight-loss therapy. The medication is not FDA-approved under this brand; it is a custom-compounded injectable produced while brand-name semaglutide remains on the FDA shortage list.
What Is Hims Compounded Semaglutide?
Hims and Hers launched its GLP-1 weight-loss program in 2024 as an affordable alternative to cash-pay Wegovy. After an online medical intake, eligible members receive a prescription for compounded semaglutide, which is shipped monthly in a multi-dose vial along with syringes. The company advertises physician oversight, titration support, and a flat monthly price.
The active ingredient is chemically the same glucagon-like peptide-1 receptor agonist found in Ozempic and Wegovy. However, instead of being manufactured in an FDA-approved facility, it is mixed by a licensed compounding pharmacy using semaglutide active pharmaceutical ingredient (API) and sterile diluents.
FDA 503A vs 503B: Why Compounding Exists
The U.S. Food, Drug, and Cosmetic Act carves out space for pharmacy compounding in two sections:
| Category | Who Regulates | Prescription Required | Typical Use |
|---|---|---|---|
| 503A pharmacy | State boards of pharmacy | Yes, patient-specific | Personalized doses for individual patients |
| 503B outsourcing facility | FDA directly | No, can be office stock | Larger-scale sterile compounding for clinics and hospitals |
Most telehealth GLP-1 programs, including Hims, rely on 503A pharmacies. Under federal law these pharmacies can compound a drug appearing on the FDA shortage list. Because semaglutide has been on that list, compounding is currently permitted. If the FDA declares the shortage resolved, much of the compounded market would need to stop producing semaglutide.
How the Hims Program Works
The standard patient experience looks like this:
- Complete an online intake with medical history, weight, and goals.
- A licensed clinician reviews the information and decides whether semaglutide is appropriate.
- If approved, a partner pharmacy ships the first vial with syringes and instructions.
- Most members start at a low dose (commonly 0.25 mg weekly) and titrate every 4 weeks as tolerated.
- Monthly check-ins, messaging, and dose adjustments are included in the membership fee.
Hims publishes monthly pricing for its compounded GLP-1 program that is substantially lower than cash-pay Wegovy. Exact amounts vary by plan length and dose. The company does not bill commercial insurance for compounded semaglutide because the product is not FDA-approved.
How Semaglutide Works for Weight Loss
Semaglutide activates GLP-1 receptors in the pancreas, gut, and brain. This increases glucose-dependent insulin release, suppresses glucagon, slows gastric emptying, and reduces appetite and food reward signals. Over months, most people experience less hunger, smaller meal portions, and gradual weight loss. The STEP clinical trials of brand-name semaglutide showed average weight reductions near 15 percent of body weight at higher maintenance doses.
Whether compounded versions produce identical results depends on the API used, the sterile technique of the compounder, and adherence to the titration schedule. For foundational information on insulin and glucose metabolism, see the prediabetes 101 hub.
Benefits People Cite
Why do members choose Hims compounded semaglutide rather than brand-name Wegovy?
- Lower monthly cost than cash-pay brand-name semaglutide.
- Telehealth access without in-person clinic visits.
- Bundled clinician support and titration guidance.
- Access when insurance denies coverage for Wegovy or Ozempic.
Weight loss itself can improve blood pressure, lipid profile, and glycemic metrics, which is relevant to anyone managing prediabetes. Pair any medication with the practical steps discussed in the treatment hub.
Safety Considerations and FDA Warnings
Compounded drugs are not FDA-reviewed for safety or efficacy. Because of this, the agency has repeatedly warned consumers about potential risks in the compounded GLP-1 market. According to FDA guidance on compounded semaglutide, key concerns include:
- Use of semaglutide sodium or acetate salts that are not the same active ingredient as Ozempic or Wegovy.
- Dosing errors when patients draw from multi-dose vials using U-100 insulin syringes.
- Variability in potency and sterility across pharmacies.
- Reports of hospitalizations tied to dosing mistakes.
Common side effects of semaglutide itself include nausea, vomiting, diarrhea, constipation, and abdominal pain. Rare but serious adverse events include pancreatitis, gallbladder disease, kidney injury, and a boxed warning for thyroid C-cell tumors.
Questions to Ask Before You Start
If you are considering Hims compounded semaglutide, ask your telehealth clinician:
- Which compounding pharmacy will dispense my prescription, and is it state-licensed?
- What form of semaglutide is used (base, sodium, acetate)?
- How is sterility and potency tested? Can I see a certificate of analysis?
- What happens to my treatment plan if semaglutide leaves the FDA shortage list?
- How is dose escalation monitored, and who answers questions between appointments?
These questions help you separate well-run programs from lightly regulated operations. Parallel offerings include Medvi and Hers semaglutide, each of which has different pharmacy partners and pricing.
Who Should Avoid Compounded Semaglutide?
Do not use semaglutide, compounded or brand-name, if you have a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2. It is not recommended during pregnancy or breastfeeding. People with a history of pancreatitis, severe gastroparesis, or diabetic retinopathy should discuss risks carefully with their clinician.
The Bottom Line
Hims compounded semaglutide makes GLP-1 therapy more affordable and more accessible through telehealth, but it sits in a regulatory gray zone that depends on continued FDA shortage status and on the quality of individual compounding pharmacies. If you choose this route, verify the pharmacy, understand the dosing, watch for red-flag side effects, and coordinate with a clinician who knows your medical history.
Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or qualified healthcare provider with any questions about a medical condition or medication.
